Clinical Trials Browser

Hemoglobinuria, Paroxysmal, Hodgkin Disease, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

NCT00143559 2009-01-29

Stem Cell Transplantation as Immunotherapy for Hematologic Malignancies

Phase 2 Completed

17 enrolled

LymphoidMyeloidOther hematologic neoplasm

Hemoglobinuria, Paroxysmal, Hodgkin Disease, Leukemia, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

NCT00152139 2009-01-29

Stem Cell Transplantation for Patients With Hematologic Malignancies

Phase 3 Completed

33 enrolled

LymphoidMyeloidOther hematologic neoplasm

Hemoglobinuria, Paroxysmal, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

NCT00186823 2009-01-29

Haploidentical Stem Cell Transplantation for Patients With Hematologic Malignancies

Phase 3 Completed

57 enrolled

LymphoidMyeloidOther hematologic neoplasm

Hemoglobinuria, Hemoglobinuria, Paroxysmal, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Juvenile

Clinical Trials

MORPHEUS HR+BC

Safety Study of Radio-labeled huA33 Antibody in Colorectal Cancer

HAIC Combined With Lenvatinib and Sintilimab for Hepatocellular Carcinoma With PVTT

Vaccine Combining Multiple Class I Peptides and Montanide ISA 51VG With Escalating Doses of Anti-PD-1 Antibody Nivolumab or Ipilimumab With Nivolumab For Patients With Resected Stages IIIC/ IV Melanoma

Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma

PembroRad

Multiple Class I Peptides & Montanide ISA 51 VG w Escalating Doses of Anti-PD-1 ab BMS936558

A Study to Assess the Safety and Pharmacokinetics of MOXR0916 and Atezolizumab (Also Known as MPDL3280A or Anti-PD-L1) in Participants With Locally Advanced or Metastatic Solid Tumors

A Study of Atezolizumab in Combination With Carboplatin + Paclitaxel or Carboplatin + Nab-Paclitaxel Compared With Carboplatin + Nab-Paclitaxel in Participants With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower131]

A Study of Atezolizumab in Advanced Solid Tumors

Phase 1 Study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody in Solid Tumors

Haploidentical Stem Cell Transplant for Treatment Refractory Hematological Malignancies

Stem Cell Transplantation as Immunotherapy for Hematologic Malignancies

Stem Cell Transplantation for Patients With Hematologic Malignancies

Haploidentical Stem Cell Transplantation for Patients With Hematologic Malignancies